文献速递临床微生物质量管理与危急值

囊性纤维化患者中洋葱伯克霍尔德菌复合体抗菌药物敏感性试验方法评估

Evaluation of Antimicrobial Susceptibility Testing Methods for Burkholderia cenocepacia and Burkholderia multivorans Isolates from Cystic Fibrosis Patients.
PubMed 文献 · J Clin Microbiol · 2021-09-15

该研究评估了纸片扩散法、肉汤微量稀释法和MicroScan WalkAway对50株洋葱伯克霍尔德菌和50株多噬伯克霍尔德菌的重复性和准确性。结果显示仅美罗培南的纸片扩散法满足所有准确性标准,MicroScan WalkAway无药物达标,数据总体支持EUCAST不推荐常规药敏试验的立场。

要点

  • 肉汤微量稀释法仅美罗培南和米诺环素重复性≥95%。
  • 纸片扩散法3 mm界值时所有药物重复性<90%。
  • MicroScan WalkAway无药物满足准确性标准。

核心结论

  • 纸片扩散法仅美罗培南满足所有准确性标准,MicroScan WalkAway无药物达标,数据总体支持EUCAST建议。

研究设计与样本

  • 评估纸片扩散法、肉汤微量稀释法和MicroScan WalkAway对50株洋葱伯克霍尔德菌和50株多噬伯克霍尔德菌的重复性与准确性,每种药物三重复检测。

主要发现

  • 肉汤微量稀释法仅美罗培南和米诺环素重复性≥95%,MicroScan WalkAway重复性与之相似。
  • 纸片扩散法在3 mm界值时所有药物重复性<90%。
  • 纸片扩散法与肉汤微量稀释法比较,仅美罗培南满足所有验收标准。
  • 甲氧苄啶-磺胺甲噁唑和左氧氟沙星小误差高,头孢他啶极重大误差不可接受,米诺环素、哌拉西林-他唑巴坦和环丙沙星小误差和极重大误差均不可接受。
  • MicroScan WalkAway无药物满足验收标准,误差不归因于单一菌种。

临床怎么用

  • 对囊性纤维化患者伯克霍尔德菌复合体分离株,纸片扩散法仅美罗培南结果可靠,其他药物及MicroScan WalkAway准确性不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Burkholderia cepacia complex (BCC) is known for causing serious lung infections in people with cystic fibrosis (CF). These infections can require lung transplantation, eligibility for which may be guided by antimicrobial susceptibility testing (AST). While the Clinical and Laboratory Standards Institute recommends AST for BCC, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) does not, due to poor method performance and correlation with clinical outcomes. Furthermore, limited data exist on the performance of automated AST methods for BCC. To address these issues, reproducibility and accuracy were evaluated for disk diffusion (DD), broth microdilution (BMD), and MicroScan WalkAway using 50 B. cenocepacia and 50 B. multivorans isolates collected from people with CF. The following drugs were evaluated in triplicate: chloramphenicol (CAM), ceftazidime (CAZ), meropenem (MEM), trimethoprim-sulfamethoxazole (TMP-SMX), minocycline (MIN), levofloxacin (LVX), ciprofloxacin (CIP), and piperacillin-tazobactam (PIP-TAZ). BMD reproducibility was ≥ 95% for MEM and MIN only, and MicroScan WalkAway reproducibility was similar to BMD. DD reproducibility was < 90% for all drugs tested when a 3 mm cut-off was applied. When comparing the accuracy of DD to BMD, only MEM met all acceptance criteria. TMP-SMX and LVX had high minor errors, CAZ had unacceptable very major errors (VME), and MIN, PIP-TAZ, and CIP had both unacceptable minor errors and VMEs. For MicroScan WalkAway, no drugs met acceptance criteria. Analyses also showed that errors were not attributed to one species. In general, our data agree with EUCAST recommendations.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Huse HK, Lee MJ, Wootton M, et al. Evaluation of Antimicrobial Susceptibility Testing Methods for Burkholderia cenocepacia and Burkholderia multivorans Isolates from Cystic Fibrosis Patients. J Clin Microbiol. 2021. PMID: 34524889. doi:10.1128/JCM.01447-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。